Hikma Pharmaceuticals Remains Constituent of FTSE4Good Sustainability Index

London, August 2017 – Hikma Pharmaceuticals PLC (Hikma) (LSE: HIK) (NASDAQ Dubai: HIK) (OTC: HKMPY), the fast growing multinational pharmaceutical group, continues to be recognized as a constituent of the FTSE4Good Index Series for positive environmental, social and governance practices.

Press Release Corporate 22 August 2017

Content

London, August 2017 – Hikma Pharmaceuticals PLC (Hikma) (LSE: HIK) (NASDAQ Dubai: HIK) (OTC: HKMPY), the fast growing multinational pharmaceutical group, continues to be recognized as a constituent of the FTSE4Good Index Series for positive environmental, social and governance practices.

Founded on solid philanthropic principles with a strong commitment to employees, its communities and the environment, Hikma has consistently emphasized the importance of operating sustainably by engaging with stakeholders, minimizing its environmental impact and improving transparency.

“We are pleased to remain a constituent member of the  FTSE4Good Sustainability Index in recognition of our commitment to the highest ethical principles and code of conduct. In addition to cultivating our values of integrity, excellence and transparency, we also endeavor to ensure that all our stakeholders adopt the policies, behaviours, and high levels of ethical business practices undertaken by Hikma,” said Hana Darwazeh Ramadan, Vice President of Corporate Communication and Corporate Responsibility at Hikma Pharmaceuticals, “We strive to continuously create positive impact and preserve our standing as an active player in the international arena of global welfare and ethics.”

Hikma has been an active member of the UN Global Compact (UNGC) since 2007, a voluntary coalition of some 9,500 institutions in 162 countries comprising businesses, public-sector organizations, NGOs, academic institutions, cities and municipalities among others. Hikma’s values are closely aligned with the UNGC’s principles in the areas of human rights, labor, environment and anti-corruption.

Important notice for users

You are about to access Hikma historic archive material. Any reference in these archives to Hikma products or their uses may not reflect current medical knowledge and should not be used as a source of information on the present product label, efficacy data, or safety data. Please refer to your approved national product label (SmPC) for current product information.

I have read this warning and will not be using any of the contained product information for clinical purposes.